An investigation into the effect of carbopols on the release of propranolol HCl from tablet matrices

Iranian Journal of Pharmaceutical Research

Volumn 2, Issue 1, 2003, Pages 23-27

  Mortazavi, Seyed Alireza ^a   Aboofazeli, Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbopols; Drug release; Hydrophilic matrices; Propranolol HCl; Sustained release tablets

Indexed keywords

EID: 34547934034     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/IJPR.2010.30     Document Type: Article

References (21)

1. Prichard BN, Graham BR and Cruickshank JM. New approaches to the use of beta blocking drugs in hypertension. J. Hum. Hypertens. (2000) Suppl. 1: S63-68
2. Solomon AJ, Greenberg MD, Kilborn MJ and Katz NM. Amiodarone versus a beta blocker to prevent atrial fibrillation after cardiovascular surgery. Am. Heart J. (2001) 142: 811-815
3. Acanfora D, Pinna GD, Gheorghiade M, Trojano L, Furgi G, Maestri R, Picone C, Iannuzzi GL, Marciano F and Rengo K. Effect of beta-blokade on the premature ventricular beats/heart rate relation and heart rate variability in patients with coronary heart disease and severe ventricular arrhythmias. Am. J. Ther. (2000) 7: 229-236
4. Doi M, Yano M, Kobayashi S, Kohno M, Tokuhisa T, Okuda S, Suetsugu M, Hisamatsu Y, Ohkusa T and Matsuzaki M. Propranolol prevents the development of heart failure by restoring FKBP 12.6-mediated stabilization of ryanodine receptor. Circulation (2002) 105: 1374-1379
5. th edition, Lippincott Williams & Wilkins, Baltimore (2000) 1031
6. Durrani MJ and Desai DP. Carbomer Resins for Pharmaceutical Applications. Technomic Publishing, Basel (1996) 1-50
7. Hosny EA. Polycarbophil as a controlled release matrix. Int. J. Pharm. (1993) 98: 235-238
8. nd edition, Vol. 3, Marcel Dekker, New York (1990) 199-302
9. th edition, Lippincott Williams & Wilkins, Philadelphia (1999) 229-243
10. rd edition, Prentice-Hall, New York (1993) 225-260
11. nd edition, Marcel Dekker, New York (1984) 3-94
12. nd edition, Marcel Dekker, New York (1990) 635-671
13. Shivanand P. Release of propranolol HCl from a tablet coated with a macroporous membrane. Int. J. Pharm. (1993) 92: 35-45
14. Wan L, Herg P and Wong LF. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system. Int. J. Pharm. (1991) 73: 111-116
15. Baveja SK, Ranga KV and Padmalatha K. Zero order release hydrophilic matrix tablets of beta-adrenergic blockers. Int. J. Pharm. (1987) 39: 41-45
16. Malamataris S and Ganderton D. Sustained release from matrix system comprising hydrophobic and hydrophilic (gel forming) part. Int. J. Pharm. (1997) 70: 69-75
17. Upadrashta SM and Hileman GA. Direct compression controlled release tablets using ethylcellulose matrices. Drug Dev. Ind. Pharm. (1993) 19: 449-456
18. Dabbagh MA, Ford JL, Rubinstein MH, Hogan JE and Rajabi-Siahboomi AR. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxy-propylmethylcellulose. Pharm. Dev. Technol. (1999) 4: 313-324
19. Rao YM, Veni JK and Jayasagar G. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev. Ind. Pharm. (2001) 2: 759-766
20. Sanchez-Lafuente C, Teresa Faucci M, Fernandez-Arevalo M, Alvarez-Fuentes J, Rabasco AM and Mura P. Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers. Int. J. Pharm. (2002) 234: 213-221
21. United States Pharmacopeia (USP 22 & NF 17). United States Pharmacopeial Convention Inc., Rockville (1990) 1176